A month has gone by since the last earnings report for Intersect ENT (XENT). Shares have lost about 0.6% in that time frame, outperforming the S&P 500. Will the recent negative trend continue leading ...
Intersect ENT (XENT) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.34 per share a year ago. These figures are ...
It may have taken an order from the Federal Trade Commission to get there—and Medtronic may be getting less bang for its buck than initially expected—but the medtech giant’s acquisition of Intersect ...
Staying true to its pledge to crack down on potentially anticompetitive megamergers in the healthcare industry, the U.S. Federal Trade Commission has ordered Medtronic and Intersect ENT to adjust the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results